Cargando…

A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Despite the progress that has been made in other forms of cancer therapy, Provenge® (Sipuleucel-T) is the only FDA-approved vaccine for the treatment of cancer. To understand the current landscape of therapeutic oncology vaccines we performed a quantitative analysis of phase 2 and phase 3 therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Amabel CL, Goubier, Anne, Kohrt, Holbrook E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647658/
https://www.ncbi.nlm.nih.gov/pubmed/26579225
http://dx.doi.org/10.1186/s40425-015-0093-x

Ejemplares similares